This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Brad Stone - Innovator in Immunogenic Compositions
Introduction
Brad Stone is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of immunology through his innovative work on immunogenic compositions. His research focuses on developing methods to generate immune responses that can be utilized in vaccine compositions.
Latest Patents
Brad Stone holds a patent for "Immunogenic compositions, antigen screening methods, and methods of generating immune responses." This patent describes an immunogenic composition that is designed to identify and select immunogenic antigens that elicit immune responses in subjects. The compositions may include a variety of nucleic acid fragments or minigenes derived from a nucleic acid library, each encoding different antigens associated with various diseases or conditions. The delivery medium for these compositions is engineered to minimize antigenic competition among individual antigen presenting cells.
Career Highlights
Brad Stone is affiliated with the University of Washington, where he continues to advance his research in immunology. His work has the potential to impact vaccine development significantly, addressing multiple diseases and conditions through innovative approaches.
Collaborations
Brad collaborates with Sean C. Murphy, enhancing the research efforts in their field. Their combined expertise contributes to the advancement of immunogenic research and its applications.
Conclusion
Brad Stone's innovative work in immunogenic compositions showcases his dedication to advancing medical science. His contributions are paving the way for new vaccine technologies that could improve health outcomes globally.